CC
CDLX icon

Chase Coleman’s Cardlytics CDLX Stock Holding History

Chase Coleman’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,494
Closed -$8.82M – 99
2020
Q3 		$8.82M Hold
12,494
– – 0.02% 67
2020
Q2 		$8.74M Hold
12,494
– – 0.03% 54
2020
Q1 		$4.37M Sell
12,494
-33,016
-73% -$23.4M 0.03% 57
2019
Q4 		$28.6M Buy
+45,510
New +$22.3M 0.16% 44

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
ACM
Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Chase Coleman's CDLX Position: Q4 2020 in Review

Chase Coleman sold out of Cardlytics (CDLX) in Q4 2020, closing a stake of 12,494 shares — an estimated $8.82M sold.

Chase Coleman first reported a position in CDLX in Q4 2019 and held it in 4 quarters. The position peaked at $28.6M in Q4 2019. 195 funds tracked by Wall St. Rank hold CDLX as of Q4 2020.

  • Chase Coleman reported no remaining Cardlytics position as of Q4 2020 after selling out during the quarter.
  • Chase Coleman sold 12,494 Cardlytics shares in Q4 2020, an estimated $8.82M.
  • Chase Coleman first reported a position in Cardlytics in Q4 2019 and held it in 4 quarters.
  • Chase Coleman's Cardlytics position peaked at $28.6M in Q4 2019.
  • 195 funds tracked by Wall St. Rank held Cardlytics as of Q4 2020.

Based on Tiger Global Management's 13F filing for Q4 2020, filed 16 Feb 2021.